A Court Decision on "Skinny Labeling": Another Challenge for Less Expensive Drugs

JAMA. 2021 Oct 12;326(14):1371-1372. doi: 10.1001/jama.2021.0006.
No abstract available

MeSH terms

  • Drug Labeling / legislation & jurisprudence*
  • Drugs, Generic* / economics
  • Legislation, Drug
  • Patents as Topic*
  • Pharmaceutical Preparations / economics
  • Therapeutic Equivalency
  • United States
  • United States Food and Drug Administration

Substances

  • Drugs, Generic
  • Pharmaceutical Preparations